Back to results

University of Texas Health Science Center at Houston

Novel Mechanisms of Antigen Processing That Enhance Bcg Vaccine Efficacy

Abstract

dc:description.abstract

<p><em>Mycobacterium tuberculosis,</em> the causative agent of tuberculosis, is the most lethal single infectious agent afflicting man today causing 2 million deaths per year. The World Health Organization recommends a vaccine as the best option to prevent this disease. The current vaccine, BCG, has a variable efficacy and does not protect adults. It is known that BCG vaccine becomes sequestered in special phagosome compartments of macrophages that do not fuse with lysosomes. Since lysosome fusion is necessary for peptide production and T cell priming leading to protective T<sub>H</sub>1 immunity, we hypothesized that vaccine efficacy is reduced and occurs perhaps due to non-lysosome dependent mechanisms. We therefore proposed an in depth analysis of phagosome environment, and its proteome to unravel mechanisms of antigen processing and presentation. We initially discovered that three mechanisms of pH regulation including vacuolar proton ATPase, phagocyte oxidase and superoxide dismutase (SOD) secretion from BCG vaccine affect antigen processing within phagosomes. These studies led to the discovery that a mutant of BCG vaccine which lacked SOD was a better vaccine. Subsequently, the proteomic analysis of vaccine phagosomes led to the discovery of novel protease (γ-secretase) enriched on BCG vaccine phagosomes. We then demonstrated that these proteases generated a peptide from the BCG vaccine which was presented through the MHC-II pathway to T cells and induced a T<sub>H</sub>1 response. The specificity of antigen production from γ-secretase was confirmed through siRNA knockdown of the components of the protease namely, nicastrin, presenilin and APH, which led to a decrease in antigen presentation. We therefore conclude that, even though BCG phagosomes are sequestered and do not fuse with lysosomes to generate peptide antigens, there are complex and novel <em>in situ</em> mechanisms within phagosomes that are capable of generating an immune response. We conclude that T<sub>H</sub>1 immunity to BCG vaccine arises mostly due to non-lysosome dependent immune mechanisms of macrophages and dendritic cells.</p>

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation (PhD)
Year dc:date.available
2011

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Singh, Christopher R
Contributors dc:contributor
  • Chinnaswamy Jagannath, Ph.D.
  • Fernando Cabral, Ph.D.
  • Andrew Bean, Ph.D.

Subjects

dc:subject × 9

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1201

Chain of custody

source
Harvested from
University of Texas Health Science Center at Houston
Base URL
digitalcommons.library.tmc.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Singh, Christopher R. Novel Mechanisms of Antigen Processing That Enhance Bcg Vaccine Efficacy. Dissertation (PhD) thesis, 2011. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/171